Cannara Biotech Inc.

Cannara Biotech Inc.

LOVFF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$141.26M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cannara Biotech Inc.Cannara Biotech Inc.17.9-9%1.40.3
$2.60

Current Fair Value

85.4% upside

Undervalued by 85.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$141.26 Million
Enterprise Value$156.68 Million
Earnings per Share$0.14
Beta0.4
Outstanding Shares98,782,148

Return

Return on Equity8.63%ROE
Return on Assets5.58%
Return on Invested Capital11.45%

Valuation & Multiples

P/E Ratio17.87P/E Ratio
PEG105.67PEG
Price to Sales1.4Price to Sales
Price to Book Ratio1.4Price to Book Ratio
Enterprise Value to Revenue1.33
Enterprise Value to EBIT8.45
Enterprise Value to Net Income14
Total Debt to Enterprise0.24
Debt to Equity0.3Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
July 15, 2026
EPS
$0.04
Est. $0.04
Revenue
$22.67 M
Est. $22.63 M

Next Earnings Call

Expected Date
November 23, 2026
EPS Estimate
$0.03
Consensus analyst estimate
Revenue Estimate
$24.11 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Cannara Biotech Inc.

452 employees
CEO: Zohar Krivorot

Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing bo...